AI Science Tracker
EN

AI-based characterization of lymphoid structures and the tumor microenvironment reveals lower mature tertiary lymphoid structures, lymph-node follicles, and plasma cells after neoadjuvant therapy in l

University of Pennsylvania; University of California, San Francisco · 9 Nov 2026 · medicine

Discovery

AI-based characterization of lymphoid structures and the tumor microenvironment reveals lower mature tertiary lymphoid structures, lymph-node follicles, and plasma cells after neoadjuvant therapy in l

Source check: Source checked. Not independent scientific confirmation.

Finding: Deep-learning models quantified immune cells and lymphoid structures in lung squamous-cell carcinoma samples. In a 40-patient discovery cohort, neoadjuvant-treated cases had fewer stromal plasma cells and fewer mature tertiary or secondary lymphoid structures in specified compartments; an independent 458-patient cohort linked stromal plasma-cell density and lymphocyte–plasma-cell colocalization with longer survival. The observational comparison does not show that treatment caused these differences.

Technology: Deep-learning tissue and cell models quantified immune-cell densities, co-localization, and TLS/SLS maturity from H&E slides, supporting comparison of tumor and lymph-node immune architecture.

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Deep-learning tissue and cell models quantified immune-cell densities, co-localization, and TLS/SLS maturity from H&E slides, supporting comparison of tumor and lymph-node immune architecture.
Test and result
The TLS model was evaluated on held-out annotated slides; the study also tested survival associations in an independent 458-patient cohort.
Limitation / still unknown
Small observational treatment comparison; model errors and cohort differences limit interpretation, and causal treatment effects are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://arxiv.org/abs/2611.12855v1

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary full text, including Methods and Results; first result-bearing version and date verified from primary record..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.